40/60 Release 24 HR methylphenidate hydrochloride 30 MG Extended Release Oral Capsule
RxCUI: 1806206
What the CMS Formulary Data Shows for 40/60 Release 24 HR methylphenidate hydrochloride 30 MG Extended Release Oral Capsule
Per the CMS 2026 Part D formulary file, 40/60 Release 24 HR methylphenidate hydrochloride 30 MG Extended Release Oral Capsule (RxNorm concept RXCUI 1806206) appears on 19 distinct formulary files spanning 166 Medicare Part D plan offerings - 3.3% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.4.
Real-world access to 40/60 Release 24 HR methylphenidate hydrochloride 30 MG Extended Release Oral Capsule depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 84.2% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 40/60 Release 24 HR methylphenidate hydrochloride 30 MG Extended Release Oral Capsule today.
Coverage Details
- Formularies covering
- 19
- Plans covering
- 166
- Coverage rate
- 3.3%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 84.2% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 40/60 Release 24 HR methylphenidate hydrochloride 30 MG Extended Release Oral Capsule
100 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is 40/60 Release 24 HR methylphenidate hydrochloride 30 MG Extended Release Oral Capsule covered by Medicare Part D?
Yes, 40/60 Release 24 HR methylphenidate hydrochloride 30 MG Extended Release Oral Capsule is covered by 166 Medicare Part D plans (3.3% of all Part D formularies).
What tier is 40/60 Release 24 HR methylphenidate hydrochloride 30 MG Extended Release Oral Capsule on Medicare Part D plans?
40/60 Release 24 HR methylphenidate hydrochloride 30 MG Extended Release Oral Capsule averages Tier 2.4 across Part D plans, ranging from Tier 1 to Tier 4.
Does 40/60 Release 24 HR methylphenidate hydrochloride 30 MG Extended Release Oral Capsule require prior authorization?
0% of Part D formularies require prior authorization for 40/60 Release 24 HR methylphenidate hydrochloride 30 MG Extended Release Oral Capsule. Step therapy: 0%. Quantity limits: 84.2%.
Read our methodology - how this data is sourced, computed, and verified.